Outcome Prediction in Patients with Severe COVID-19 Requiring Extracorporeal Membrane Oxygenation-A Retrospective International Multicenter Study
In this study, we assess survival in an international multicenter cohort of COVID-19 patients treated with V-V ECMO and evaluate the performance of several clinical scores to predict 30-day survival.
Efficacy of Multidisciplinary Team Approach with Extracorporeal Membrane Oxygenation for COVID-19 in Low Volume ECMO Center
Veno-venous extracorporeal membrane oxygenation (VV ECMO) is an effective and proven adjunct support for various severe respiratory failure requiring invasive mechanical ventilation and cardiovascular support. In response to the rapidly increasing number of COVID-19 patients in Japan, we launched an ECMO support team comprised of multidisciplinary experts including physicians, nurses, perfusionists, and bioethicists in preparation for the threat of a pandemic.
Comparison of Anticoagulation Strategies in Patients Requiring Venovenous Extracorporeal Membrane Oxygenation: Heparin Versus Bivalirudin
We sought to compare extracorporeal membrane oxygenation circuit thrombosis and bleeding-related outcomes in respiratory failure patients receiving either unfractionated heparin or bivalirudin for anticoagulation on venovenous extracorporeal membrane oxygenation support.
Practical Considerations and Outcomes of Inter-facility ECMO Transfer of COVID-19 Patients During a Pandemic: The Mayo Clinic Experience
We report our designated ECMO transport team's experience with five patients with COVID19 associated severe ARDS after cannulation at the referring facility. Focusing on transport associated logistics, creation of checklists, and collaboration with EMS partners is necessary for safe and good outcomes for patients while maintaining team safety.
ABCP Annual Report 2020
Even in normal times, working as a Certified Clinical Perfusionist (CCP) has its challenges. With a changing patient population, evolving technologies, advancing techniques, and shifting practice dynamics, CCPs are asked to do more and readily adapt to practice changes whenever they present themselves.
VV ECMO Strategies for COVID-19, A Single Center Experience
Topics covered in this webinar included patient selection and management, cannulation preference, extracorporeal circuit design, staffing models and personal protective equipment.
Perfusion.com Jobs – July Update 2020
Perfusion.com Jobs: We are always seeking out the best and brightest current and future leaders for employment opportunities within our company.
In Memory of Ray Childress
It is with a sad heart we want to inform the perfusion community that Ray Childress passed away this week after a long, brave and hard-fought battle with various health issues.
Joint Perfusion COVID-19 Task Force Webinar 5/14/2020
Join the Joint Perfusion COVID-19 Task Force for the next live webinar on Thursday, May 14 to hear from physicians from around the world on COVID-19 treatments, reopening ORs, and starting up CPB again.
CytoSorbents Devices Wins Emergency Approval to Treat COVID-19 Patients
The Food and Drug Administration says it granted Emergency Use Authorization for CytoSorbent’s (NASDAQ:CTSO) CytoSorb device to treat patients with confirmed Covid-19 admitted to the ICU with confirmed or imminent respiratory failure.
Compassionate Use of Remdesivir for Patients with Severe Covid-19
We provided remdesivir on a compassionate-use basis to patients hospitalized with Covid-19, the illness caused by infection with SARS-CoV-2.
Coagulopathy and Antiphospholipid Antibodies in Patients with Covid-19
We describe a patient with Covid-19 and clinically significant coagulopathy, antiphospholipid antibodies, and multiple infarcts. He was one of three patients with these findings in an intensive care unit designated for patients with Covid-19.